This paper provides a description of an alternative, novel and commercially viable process which has been developed for the preparation of Azilsartan, a pro-drug of Azilsartan medoxomil, an angiotensin II receptor blocker. The present work also provides a primary account of the synthesis and characterization of the novel intermediates (6, 7 & 10) of Azilsartan, with their spectral data.
© 2015 Srinivas Garaga, Nimesh C. Misra, Ambati V. Raghava Reddy, Koilpillai Joseph Prabahar, Chandiran Takshinamoorthy, Paul Douglas Sanasi, Raghubabu Korupolu, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.